CD36 and neutral lipid storage myopathy: Third, 123I-BMIPP scintigraphy is also interrupted by certain illnesses, such as fatty acid translocase (FAT)/CD36 gene mutation or triglyceride deposit cardiomyovasculopathy (TGCV).